FSMDX
Price
$42.33
Change
-$0.12 (-0.28%)
Updated
Jul 31 closing price
Net Assets
52.09B
NOMIX
Price
$23.83
Change
-$0.03 (-0.13%)
Updated
Jul 31 closing price
Net Assets
2.32B
Interact to see
Advertisement

FSMDX vs NOMIX

FSMDX vs NOMIX Comparison Chart in %
View a ticker or compare two or three
VS
FSMDX vs. NOMIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and NOMIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 52.1B vs. NOMIX (2.32B). NOMIX pays higher dividends than FSMDX: NOMIX (1.18) vs FSMDX (0.76). FSMDX was incepted earlier than NOMIX: FSMDX (15 years) vs NOMIX (21 years). NOMIX (0.16) is less costly to investors than FSMDX (0.03). NOMIX is a more actively managed with annual turnover of: 15.97 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than NOMIX: FSMDX (0) vs NOMIX (2500). FSMDX annual gain was more profitable for investors over the last year : 18.74 vs. NOMIX (14.62). FSMDX return over 5 years is better than : 42.85 vs. NOMIX (3.32).
FSMDXNOMIXFSMDX / NOMIX
Total Expense Ratio0.030.1025%
Annual Report Gross Expense Ratio0.030.1616%
Fund Existence15 years21 years-
Gain YTD14.62214.567100%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets52.1B2.32B2,245%
Annual Yield % from dividends0.761.1865%
Returns for 1 year18.7414.62128%
Returns for 3 years50.0918.88265%
Returns for 5 years42.853.321,291%
Returns for 10 years165.6455.74297%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EAGL33.930.45
+1.34%
Eagle Capital Select Equity ETF
QDVO28.960.27
+0.94%
Amplify CWP Growth & Income ETF
SCMC24.94-0.01
-0.04%
Sterling Capital Multi-Strat Inc ETF
NUBD21.76-0.06
-0.27%
Nuveen ESG US Aggregate Bond ETF
RXL55.10-0.73
-1.31%
ProShares Ultra Health Care